Cytoreduction of Residual Tumor Burden Is Decisive for Prolonged Survival in Patients with Recurrent Brain Metastases—Retrospective Analysis of 219 Patients
Background: Despite advances in treatment for brain metastases (BMs), the prognosis for recurrent BMs remains poor and requires further research to advance clinical management and improve patient outcomes. In particular, data addressing the impact of tumor volume and surgical resection with regard t...
Main Authors: | Jonas Lin, Yannik Kaiser, Benedikt Wiestler, Denise Bernhardt, Stephanie E. Combs, Claire Delbridge, Bernhard Meyer, Jens Gempt, Amir Kaywan Aftahy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/20/5067 |
Similar Items
-
A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis
by: A. Kaywan Aftahy, et al.
Published: (2023-02-01) -
Enhancing outcomes: neurosurgical resection in brain metastasis patients with poor Karnofsky performance score - a comprehensive survival analysis
by: Maria Goldberg, et al.
Published: (2024-01-01) -
Brain metastases in the elderly – Impact of residual tumor volume on overall survival
by: Lea Baumgart, et al.
Published: (2023-04-01) -
Metabolic Parameters Influence Brain Infarction and Outcome after Resection of Brain Metastases
by: Nicole Lange, et al.
Published: (2020-04-01) -
Editorial: Radiotherapy strategies for precise treatment on brain metastases
by: Eric J. Lehrer, et al.
Published: (2024-03-01)